Loading..
  • SynAct Pharma logoSVE
  • SynAct Pharma logoENG
  • About us
    • The Company in brief
    • Vision
    • Mission
    • History
    • Organisation
    • Collaborations and Partnerships
  • Our Science
    • Resolving Inflammation
    • The Melanocortin System and Inflammation
    • SynAct’s Technology – Selective Melanocortin Stimulation
    • Scientific Advisory Board
  • Pipeline
    • Pipeline Overview
    • The AP1189 Development Program
      • Rheumatoid Arthritis
      • Membranous Nephropathy
      • Virus Induced Respiratory Insufficiency
    • Peptide Agonists
      • TXP-11
    • Ongoing clinical studies
  • Investors
    • Capital Markets Day 2023
    • Listing Nasdaq 2022
    • Rights Issue 2022
    • Word from the CEO
    • Financial Reports
    • Investment highlights
    • Presentations
    • The Share
      • Share price development
      • Ownership Structure
      • Insiders
      • Share Capital Development
    • Analyst Coverage
    • Calendar
    • Press Releases
    • Prospectuses
  • Governance
    • General Meetings
    • Corporate Governance Report
    • Nomination Committee
      • Nomination Committee 2023
    • Board of Directors
      • Remuneration Committee
      • Audit Committee
      • R&D Committee
    • Management
    • Auditor
    • Articles of Association
    • Code of Conduct
  • Media
    • Press Releases
    • Synact in Media
    • Image Bank
    • Subscribe
  • Contact

Calendar

2022
  • Upcoming events
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • All years
  • 10
    Jan
    January 10 - January 14, 2022
    JP Morgan in San Fransisco
    Add to calendar
  • 11
    Feb
    February 11, 2022
    Year-end report 2021
    Add to calendar
  • 28
    Mar
    March 28, 2022
    Extraordinary General Meeting March 2022
    Add to calendar
  • 28
    Mar
    March 28 - March 31, 2022
    Bio-Europe Spring
    Add to calendar
  • 28
    Mar
    March 28, 2022 10:00 CET
    Conference Call regarding Rights Issue 2022
    Add to calendar
  • 21
    Apr
    April 21, 2022
    Kempen Life Science Conference
    Add to calendar
  • 25
    Apr
    April 25, 2022
    Sedermeradagen – Hotel at Six, Stockholm
    Add to calendar
  • 29
    Apr
    April 29, 2022
    Annual Report 2021
    Add to calendar
  • 02
    May
    May 2, 2022
    Aktiespararna – Aktiedagen Stockholm
    Add to calendar
  • 18
    May
    May 18 - May 19, 2022
    ABGSC Life Science Summit
    Add to calendar
  • 20
    May
    May 20, 2022
    Annual General Meeting 2022
    Add to calendar
  • 30
    May
    May 30, 2022
    Interim Report Q1 2022
    Add to calendar
  • 01
    Jun
    June 1, 2022
    Økonomisk Ugebrev – Life Science Event Copenhagen
    Add to calendar
  • 08
    Jun
    June 8 - June 9, 2022
    BioStock Life Science Summit Spring
    Add to calendar
  • 13
    Jun
    June 13 - June 16, 2022
    BIO International Convention – San Diego, CA
    Add to calendar
  • 11
    Jul
    July 11, 2022
    Last day of trade of the SYNACT share at Spotlight Stock Market
    Add to calendar
  • 12
    Jul
    July 12, 2022
    First day of trade of the SYNACT share at Nasdaq Stockholm
    Add to calendar
  • 05
    Aug
    August 5, 2022
    Interim Report Q2 2022
    Add to calendar
  • 06
    Sep
    September 6 - September 7, 2022
    LSX Nordic Congress 2022 – Bella Sky Convention Center, Copenhagen
    Add to calendar
  • 28
    Sep
    September 28 - September 29, 2022
    NLSDays 2022
    Add to calendar
  • 04
    Nov
    November 4, 2022
    Interim Report Q3 2022
    Add to calendar
  • 14
    Nov
    November 14, 2022
    ACR Convergence 2022
    Add to calendar
  • 12
    Dec
    December 12, 2022 14:00 CET
    Telephone conference regarding the acquisition of TXP Pharma
    Add to calendar
  • Investors
    • Capital Markets Day 2023
    • Listing Nasdaq 2022
    • Rights Issue 2022
    • Word from the CEO
    • Financial Reports
    • Investment highlights
    • Presentations
    • The Share
      • Share price development
      • Ownership Structure
      • Insiders
      • Share Capital Development
    • Analyst Coverage
    • Calendar
    • Press Releases
    • Prospectuses
Torbjørn Bjerke
Torbjørn Bjerke
Chief Executive Officer
+46 727 44 41 58
[email protected]
Patrik Renblad, MSc.
Patrik Renblad, MSc.
Chief Financial Officer
+4670 747 97 68
[email protected]

About Synact Pharma

SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. Selective activation of the melanocortin system can help the immune system resolve excessive or chronic inflammation.

  • Privacy Policy
  • Cookies

Explore our Website

  • About us
  • Our Science
  • Pipeline
  • Investors
  • Governance
  • Media
  • Contact
  • LinkedIn

Subscribe